|
GNA12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.450990E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.863400E-03 |
| Normal-vs-Stage2 |
2.840000E-01 |
| Normal-vs-Stage3 |
5.245200E-01 |
| Normal-vs-Stage4 |
7.670600E-01 |
| Stage1-vs-Stage2 |
5.245000E-01 |
| Stage1-vs-Stage3 |
6.896200E-02 |
| Stage1-vs-Stage4 |
4.748200E-01 |
| Stage2-vs-Stage3 |
2.309600E-01 |
| Stage2-vs-Stage4 |
8.287200E-01 |
| Stage3-vs-Stage4 |
5.416000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.956300E-02 |
| Normal-vs-AfricanAmerican |
2.745000E-01 |
| Normal-vs-Asian |
3.287800E-01 |
| Caucasian-vs-AfricanAmerican |
7.823000E-01 |
| Caucasian-vs-Asian |
8.852400E-01 |
| AfricanAmerican-vs-Asian |
8.122000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.061600E-03 |
| Normal-vs-Female |
1.739180E-01 |
| Male-vs-Female |
5.803600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.274410E-01 |
| Normal-vs-Extreme_Weight |
3.587900E-02 |
| Normal-vs-Obese |
8.192400E-01 |
| Normal-vs-Extreme_Obese |
6.767900E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.971400E-01 |
| Normal_Weight-vs-Obese |
2.212600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.669200E-01 |
| Extreme_Weight-vs-Obese |
1.106430E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.594200E-01 |
| Obese-vs-Extreme_Obese |
9.076300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.092600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.144600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.177000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.710300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.695820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.118300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.390000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.194040E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.036200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.793600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.745600E-02 |
| Normal-VS-Type2 PRCC |
9.037900E-03 |
| Normal-VS-KIRP CIMP |
6.919800E-02 |
| Normal-VS-Unclassified PRCC |
1.414980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.228200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.292500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.060350E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.494000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.221900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.027600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.001720E-02 |
| Normal-vs-N1 |
5.616000E-01 |
| Normal-vs-N2 |
2.415600E-01 |
| N0-vs-N1 |
7.723900E-02 |
| N0-vs-N2 |
1.720890E-03 |
| N1-vs-N2 |
2.572000E-01 |
|
|
